Full text is available at the source.
Abstract
Evaluation of the probiotic formulation VSL#3® in patients with long COVID suggests potential benefits.
- Long COVID is often linked to ongoing fatigue and reduced quality of life.
- Dysregulation of gut bacteria and immune responses may play a role in the persistence of symptoms.
- The impact of VSL#3® on long COVID symptoms is being assessed.
- Preliminary findings could indicate that this probiotic formulation may help improve patient outcomes.
Simplified